CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The purpose of this study is...
Phase 1
Houston, Texas, United States and 20 other locations
To learn if the drug combination pirtobrutinib, venetoclax, and obinutuzumab can help to control relapsed CLL/SLL.
Phase 2
Houston, Texas, United States
This phase II trial studies how well acalabrutinib and venetoclax with or without early obinutuzumab work for the treatment of chronic lymphocytic...
Phase 2
Houston, Texas, United States
The goal of this clinical research study is to learn if the combination of lenalidomide and rituximab can help to control CLL. The safety of this dru...
Phase 2
Houston, Texas, United States
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...
Phase 4
Houston, Texas, United States and 34 other locations
monotherapy in participants with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL). This study will also all...
Phase 1
Houston, Texas, United States and 21 other locations
The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing o...
Phase 2
Houston, Texas, United States and 73 other locations
This study is designed to evaluate progression-free survival (PFS) endpoint for acalabrutinib versus (vs) ibrutinib in previously treated chronic...
Phase 3
Houston, Texas, United States and 130 other locations
Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia...
Phase 3
Houston, Texas, United States and 83 other locations
levels of Pirtobrutinib in participants with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic...
Phase 2
The Woodlands, Texas, United States and 136 other locations
Clinical trials
Research sites
Resources
Legal